Patents by Inventor Clayton Tyler

Clayton Tyler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FORMULATIONS OF A SOMATOSTATIN MODULATOR
    Publication number: 20240398782
    Abstract: Described herein are formulations of a somatostatin modulator, methods of making such formulations, and methods of using such formulations in the treatment of conditions, diseases, or disorders that would benefit from modulation of somatostatin activity.
    Type: Application
    Filed: March 8, 2024
    Publication date: December 5, 2024
    Inventors: Gerald BURKE, Ian YATES, Hannah BULOVSKY, Kyle KYBURZ, Clayton TYLER
  • TRANSGENIC CORN EVENT ZM_CSM63715 AND METHODS FOR DETECTION AND USES THEREOF
    Publication number: 20240229063
    Abstract: A transgenic corn event, Zm_CSM63715, is provided. Transgenic plant cells, plant parts, plants, seeds, progeny plants, and agricultural and commodity products containing event Zm_CSM63715 are also provided. Recombinant DNA molecules unique to the event Zm_CSM63715, and methods of using and detecting Zm_CSM63715 are also provided. Corn plants containing the event Zm_CSM63715 exhibit tolerance to PPO inhibitors.
    Type: Application
    Filed: December 15, 2023
    Publication date: July 11, 2024
    Inventors: Matthew Bauer, Sarah Brown, Robert Thomas Gaeta, Michael Edward Goley, Shirley Guo, Erin Lyn Hall, Andrei Kouranov, Clayton Tyler Larue, Mingsheng Peng, Linda Rymarquis, Oscar Cornelius Sparks, JR., Xudong Ye
  • Formulations of a somatostatin modulator
    Patent number: 11957674
    Abstract: Described herein are formulations of a somatostatin modulator, methods of making such formulations, and methods of using such formulations in the treatment of conditions, diseases, or disorders that would benefit from modulation of somatostatin activity.
    Type: Grant
    Filed: January 25, 2022
    Date of Patent: April 16, 2024
    Assignee: CRINETICS PHARMACEUTICALS, INC.
    Inventors: Gerald Burke, Ian Yates, Hannah Bulovsky, Kyle Kyburz, Clayton Tyler
  • FORMULATIONS OF A SOMATOSTATIN MODULATOR
    Publication number: 20220143007
    Abstract: Described herein are formulations of a somatostatin modulator, methods of making such formulations, and methods of using such formulations in the treatment of conditions, diseases, or disorders that would benefit from modulation of somatostatin activity.
    Type: Application
    Filed: January 25, 2022
    Publication date: May 12, 2022
    Inventors: Gerald BURKE, Ian YATES, Hannah BULOVSKY, Kyle KYBURZ, Clayton TYLER
  • FORMULATIONS OF A SOMATOSTATIN MODULATOR
    Publication number: 20220071986
    Abstract: Described herein are formulations of a somatostatin modulator, methods of making such formulations, and methods of using such formulations in the treatment of conditions, diseases, or disorders that would benefit from modulation of somatostatin activity.
    Type: Application
    Filed: September 7, 2021
    Publication date: March 10, 2022
    Inventors: Gerald BURKE, Ian YATES, Hannah BULOVSKY, Kyle KYBURZ, Clayton TYLER
  • Formulations of a somatostatin modulator
    Patent number: 11266641
    Abstract: Described herein are formulations of a somatostatin modulator, methods of making such formulations, and methods of using such formulations in the treatment of conditions, diseases, or disorders that would benefit from modulation of somatostatin activity.
    Type: Grant
    Filed: September 7, 2021
    Date of Patent: March 8, 2022
    Assignee: CRINETICS PHARMACEUTICALS, INC.
    Inventors: Gerald Burke, Ian Yates, Hannah Bulovsky, Kyle Kyburz, Clayton Tyler